You are counseling a client who was just diagnosed at 29 weeks gestational age of having gestational diabetes (GDM) after completing her 3 hour glucose tolerance test. Which statement regarding GDM by the client is false and indicates additional Counseling is required?

The biophysical profile (BPP) would yield more detailed information about the fetus in this scenario. The BPP is a prenatal ultrasound evaluation that assesses fetal well-being by evaluating five biophysical variables: fetal breathing movements, fetal movements, fetal tone, amniotic fluid volume, and fetal heart rate. The BPP is a more detailed assessment of fetal well-being compared to a nonstress test and can provide valuable information about the fetus's overall health and well-being, including any potential issues or difficulties.

MSAFP screening is a blood test that can detect certain fetal abnormalities, but it does not provide detailed information about fetal well-being.

Percutaneous umbilical blood sampling (PLBS) is an invasive test that is used to obtain a sample of fetal blood for testing in cases of suspected fetal anemia or other blood disorders. Ultrasound for fetal anomalies is a diagnostic tool used to detect structural abnormalities or defects in the fetus. While it can provide some information about fetal well-being, it is not as comprehensive as the BPP in evaluating fetal health and wellness.

In some cases, an endocrinologist may also be involved in the management of gestational diabetes. The nurse can anticipate that the client will be diagnosed with gestational diabetes and will be referred to a dietician for dietary modifications and glucose monitoring during the remainder of her pregnancy. Regular prenatal care will also continue, and the healthcare provider may adjust the treatment plan based on the client's individual needs.

However, a diagnosis of Type II diabetes would not be made solely based on a failed GTT during pregnancy, as gestational diabetes is a temporary condition that usually resolves after delivery.